HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Supriatno, Selected Research

Cyclin-Dependent Kinase Inhibitor p27

1/2011Effect of intratumoral injection of mutant type p27Kip1 followed by in vivo electroporation on radiotherapy-resistant human oral tongue cancer xenografts.
9/2005Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
8/2004Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line.
12/2003Overexpression of tuberous sclerosis complex 2 exerts antitumor effect on oral cancer cell lines.
5/2003Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
10/2002Overexpression of p27(Kip1) induces growth arrest and apoptosis in an oral cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Supriatno, Research Topics

Disease

10Neoplasms (Cancer)
01/2014 - 03/2003
7Mouth Neoplasms (Oral Cancer)
07/2005 - 10/2002
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2010 - 03/2003
2Tongue Neoplasms (Tongue Neoplasm)
01/2014 - 01/2011
1Disease Progression
01/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2005
1Salivary Gland Neoplasms (Salivary Gland Cancer)
10/2004
1Tuberous Sclerosis (Bourneville's Disease)
12/2003
1Neoplasm Metastasis (Metastasis)
05/2003

Drug/Important Bio-Agent (IBA)

6Cyclin-Dependent Kinase Inhibitor p27IBA
01/2011 - 10/2002
3CyclinsIBA
09/2005 - 08/2004
3S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
09/2005 - 05/2005
3Phosphotransferases (Kinase)IBA
09/2005 - 08/2004
2Interleukin-8 (Interleukin 8)IBA
01/2014 - 12/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 12/2005
2Caspase 3 (Caspase-3)IBA
07/2005 - 06/2004
2Caspase 8 (Caspase-8)IBA
10/2004 - 06/2004
1XanthonesIBA
01/2014
1SaponinsIBA
01/2010
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2007
1NF-kappa B (NF-kB)IBA
12/2005
1vesnarinoneIBA
12/2005
1Carrier Proteins (Binding Protein)IBA
09/2005
1UbiquitinIBA
07/2005
1Ubiquitin-Protein Ligase ComplexesIBA
07/2005
1NitrogenIBA
10/2004
1OxygenIBA
10/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2004
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2004
1Cytochromes c (Cytochrome c)IBA
06/2004
1Caspase 9IBA
06/2004
1Cisplatin (Platino)FDA LinkGeneric
06/2004
1Fluorouracil (Carac)FDA LinkGeneric
06/2004
1Complementary DNA (cDNA)IBA
12/2003
1tuberous sclerosis complex 2 protein (tuberin)IBA
12/2003
1Cadherins (E-Cadherin)IBA
05/2003
1cepharanthineIBA
03/2003

Therapy/Procedure

5Heterologous Transplantation (Xenotransplantation)
01/2011 - 08/2004
2Radiotherapy
01/2011 - 08/2004